Literature DB >> 21986287

Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.

Dirk Westermann1, Kostantinos Savvatis, Diana Lindner, Christin Zietsch, Peter Moritz Becher, Elke Hammer, Markus M Heimesaat, Stefan Bereswill, Uwe Völker, Felicitas Escher, Alexander Riad, Johanna Plendl, Karin Klingel, Wolfgang Poller, Heinz-Peter Schultheiss, Carsten Tschöpe.   

Abstract

BACKGROUND: Myocarditis is an important cause for cardiac failure, especially in younger patients, followed by the development of cardiac dysfunction and death. The present study investigated whether gene deletion of matrix metalloproteinase-2 influences cardiac inflammation and function in murine coxsackievirus B3 (CVB3)-induced myocarditis. METHODS AND
RESULTS: Matrix metalloproteinase-2 knockout mice (MMP-2(-/-)) and their wild-type controls (WT) were infected with CVB3 to induce myocarditis. Three days after infection, an increased invasion of CD4(+)-activated T cells into the myocardium was documented, followed by an excess of inflammatory cells 7 days after infection, which was significantly higher in the MMP-2(-/-)animals compared with the WT animals. Moreover, cardiac apoptosis, remodeling, viral load, and function were deteriorated in MMP-2(-/-) animals after CVB3 infection. This overwhelming inflammation was followed by 100% mortality after 15 days. This was associated with increased levels of MCP-3 in the cardiac tissue of MMP-2(-/-) mice. Because MMP-2 cleaves the chemokine MCP-3, the loss of this cleavage lead to an overreaction of the immune system with pronounced myocardial damage mediated by the inflammatory cells. When a neutralizing antibody against MCP-3 was given to MMP-2(-/-) mice, this exaggerated reaction of the immune system could be normalized to levels similar to WT-CVB3 animals.
CONCLUSIONS: Loss of MMP-2 increased the inflammatory response after CVB3 infection, which impaired cardiac function and survival during CVB3-induced myocarditis. Matrix metalloproteinase-2-mediated chemokine cleavage has an important role in cardiac inflammation as a negative feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986287     DOI: 10.1161/CIRCULATIONAHA.111.035964

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences.

Authors:  Francis G Spinale
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 2.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

Review 3.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

Review 4.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.

Authors:  N Glezeva; J A Baugh
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

Review 5.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

Review 6.  Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair.

Authors:  William P Lafuse; Daniel J Wozniak; Murugesan V S Rajaram
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

7.  Novel Resolvin D2 Receptor Axis in Infectious Inflammation.

Authors:  Nan Chiang; Xavier de la Rosa; Stephania Libreros; Charles N Serhan
Journal:  J Immunol       Date:  2016-12-19       Impact factor: 5.422

8.  Nucleotide differences of coxsackievirus B3 and chronic myocarditis.

Authors:  Chiharu Kishimoto; Nami Takamatsu; Hiroshi Ochiai; Kagemasa Kuribayashi
Journal:  Heart Vessels       Date:  2014-02-04       Impact factor: 2.037

9.  Diastolic heart failure: What we still don't know. Looking for new concepts, diagnostic approaches, and the role of comorbidities.

Authors:  C Tschöpe; C S P Lam
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

Review 10.  Targeting the chemokines in cardiac repair.

Authors:  Michele Cavalera; Nikolaos G Frangogiannis
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.